Pharma makers, distributors face painkiller investigation
Federal subpoenas are latest in opioid actions.
SUBSCRIBE: Print / eNewsletter
Federal subpoenas are latest in opioid actions.
Approval made via international collaborative effort.
Recent approval under new international Project Orbis.
FDA cites 15 companies making unsubstantiated health claims.
Hemoglobin S Polymerization inhibitor oral treatment.
PBM mergers contribute to pricing problems, ACP says.
Approved for patients 18 years of age and older
Antibiotic with a novel penetrative mechanism.
Expected U.S. launch in 2023.
First and currently only biological targeting P-selectin.
We've noticed that you're using an ad blocker
Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.